An agreement has been reached by Thermo Fisher Scientific and Swiss firm Biognosys to co-market Thermo Fisher's Orbitrap mass spectrometers and Biognosys' Spectronaut Pulsar software, which uses mass spectrometry data to allow for data-independent acquisition analyses. The deal also calls for further development and optimization of data-independent acquisition-related workflows.
Thermo Fisher enters co-marketing agreement with Biognosys
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.